ADPT: Adaptive Biotechnologies Corporation
Performance
ADPT +104.60%
Watchlist
Select an item
Summary
ADPT at a glance
ADPT returned +104.60% over the past year and -3.83% a year over five years. Its worst drop in that year was -39.35%, smaller than 38% of stocks on Redstone, and its Sharpe ratio of 1.36 beats 88% of stocks on Redstone. It pays no dividends.
Current Drawdown
0.00%
Rolling Volatility
60.79%
Actions
Metrics
Risk Indicators
Alpha75.14%
Beta1.53x
Sharpe1.36
Sortino2.14
Omega1.27
Calmar2.66
Martin4.63
Profile
About ADPT
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $4.8B
- Listed
- Jun 2019
- Employees
- 624
- Headquarters
- Seattle, WA
- Website
- adaptivebiotech.com
Comparisons